Autoimmune diseases occur when antibodies (that protect humans from foreign substances & infections) attack their own tissues & cells. This is seen more commonly in women than men. Autoimmune disease diagnostics are procedures designed for diagnosing the stage & kind of autoimmune diseases.
For Market Research Report on Autoimmune Disease Diagnostics MarketÂ Visit -http://www.grandviewresearch.com/industry-analysis/autoimmune-disease-diagnostics-industry
The autoimmune disease diagnostics market is anticipated at about USD 14.2 billion by 2020. Slow turnaround of standard procedures has coerced companies to rely on automation for faster results. Public awareness regarding these procedures expects to increase product usage during 2014 to 2020 (forecast period). Novel biomarkers and portable point-of-care diagnostic equipment will spur procedure volumes. Products of the autoimmune disease diagnostics market are systemic and localized. Localized diagnostics led the market in 2013 on account of high patient awareness and large procedure volumes. Unmet patient needs for multiple sclerosis & type 1 diabetes would drive this segment over the forecast period. Systemic will remain lucrative in the same period. These diagnostics are used to detect major disorders like systemic lupus erythematosus (SLE), rheumatoid arthritis, and ankylosing spondylitis. Large volumes of diagnostic tests and new drugs like Avise SLE marker are the key drivers of this segment. Rheumatoid arthritis is the fastest growing sub-segment of systemic diagnostics. It could grow at more than 4% CAGR in the coming six years. The autoimmune disease diagnostics market is split by regions into North America, Europe, Asia Pacific, and RoW (Rest of the World). North America was the largest market in 2013. It occupied 40% shares the same year. This was attributed to multiple autoimmune diseases and sophisticated healthcare infrastructure in the region. Initiatives like the Affordable Care Act to curb the expenditures of these diseases will also favor North America. Europe was the second largest market due to governmental funding for curbing these diseases. Asia Pacific should experience significant growth in the future. The improving Indian and Chinese markets are estimated to provide regional opportunities. Development of advanced tests for detecting IgG (Immunoglobulin G) & IgA (Immunoglobulin A) antibodies is a strategy used by market companies to gain shares. Prominent companies of the global autoimmune disease diagnostics market comprise Roche Diagnostics, Abbott Laboratories, Siemens Healthcare, Bio-Rad Laboratories Inc., and Quest Diagnostics.
Information Source: Grand View Research